Fidelity Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$499M Sell
1,283,180
-261,407
-17% -$102M 0.03% 486
2025
Q1
$672M Sell
1,544,587
-648,144
-30% -$282M 0.04% 352
2024
Q4
$809M Sell
2,192,731
-2,426,019
-53% -$895M 0.05% 312
2024
Q3
$2.4B Sell
4,618,750
-128,083
-3% -$66.6M 0.15% 113
2024
Q2
$2.57B Buy
4,746,833
+693,525
+17% +$376M 0.16% 88
2024
Q1
$2.1B Buy
4,053,308
+87,322
+2% +$45.3M 0.14% 115
2023
Q4
$1.87B Sell
3,965,986
-249,992
-6% -$118M 0.14% 113
2023
Q3
$1.84B Sell
4,215,978
-191,531
-4% -$83.4M 0.16% 103
2023
Q2
$1.96B Sell
4,407,509
-401,586
-8% -$178M 0.16% 101
2023
Q1
$2.21B Sell
4,809,095
-1,445,007
-23% -$664M 0.2% 86
2022
Q4
$3.21B Sell
6,254,102
-269,117
-4% -$138M 0.32% 55
2022
Q3
$2.96B Sell
6,523,219
-24,762
-0.4% -$11.2M 0.31% 52
2022
Q2
$3.16B Sell
6,547,981
-331,047
-5% -$160M 0.31% 48
2022
Q1
$3.38B Buy
6,879,028
+390,533
+6% +$192M 0.27% 53
2021
Q4
$3.01B Buy
6,488,495
+102,963
+2% +$47.7M 0.22% 65
2021
Q3
$2.38B Sell
6,385,532
-565,858
-8% -$211M 0.19% 88
2021
Q2
$2.65B Buy
6,951,390
+74,543
+1% +$28.5M 0.21% 79
2021
Q1
$2.47B Sell
6,876,847
-1,856,190
-21% -$666M 0.21% 81
2020
Q4
$2.8B Buy
8,733,037
+244,712
+3% +$78.6M 0.25% 64
2020
Q3
$2.28B Buy
8,488,325
+508,915
+6% +$137M 0.23% 76
2020
Q2
$2.1B Buy
7,979,410
+477,208
+6% +$125M 0.23% 73
2020
Q1
$1.7B Buy
7,502,202
+13,673
+0.2% +$3.1M 0.24% 82
2019
Q4
$2.26B Sell
7,488,529
-375,308
-5% -$113M 0.25% 70
2019
Q3
$1.89B Sell
7,863,837
-1,651,914
-17% -$397M 0.23% 81
2019
Q2
$2.69B Sell
9,515,751
-923,648
-9% -$261M 0.31% 56
2019
Q1
$3B Sell
10,439,399
-904,336
-8% -$260M 0.36% 44
2018
Q4
$2.98B Buy
11,343,735
+712,371
+7% +$187M 0.41% 38
2018
Q3
$2.91B Buy
10,631,364
+725,224
+7% +$199M 0.33% 46
2018
Q2
$2.36B Buy
9,906,140
+731,074
+8% +$174M 0.27% 57
2018
Q1
$2.02B Sell
9,175,066
-213,290
-2% -$46.9M 0.24% 74
2017
Q4
$2.11B Sell
9,388,356
-559,618
-6% -$126M 0.25% 72
2017
Q3
$1.89B Sell
9,947,974
-105,822
-1% -$20.1M 0.23% 78
2017
Q2
$1.89B Sell
10,053,796
-2,281,319
-18% -$429M 0.24% 76
2017
Q1
$2.04B Buy
12,335,115
+934,509
+8% +$155M 0.26% 71
2016
Q4
$1.64B Buy
11,400,606
+1,097,145
+11% +$158M 0.22% 87
2016
Q3
$1.29B Buy
10,303,461
+1,269,859
+14% +$159M 0.17% 116
2016
Q2
$1.19B Buy
9,033,602
+770,894
+9% +$101M 0.16% 133
2016
Q1
$1.15B Buy
8,262,708
+599,579
+8% +$83.3M 0.16% 132
2015
Q4
$1.07B Sell
7,663,129
-1,459,828
-16% -$204M 0.14% 144
2015
Q3
$1.28B Sell
9,122,957
-1,511,558
-14% -$212M 0.18% 117
2015
Q2
$1.75B Sell
10,634,515
-368,349
-3% -$60.5M 0.22% 88
2015
Q1
$1.7B Buy
11,002,864
+8,593
+0.1% +$1.33M 0.22% 90
2014
Q4
$1.38B Buy
10,994,271
+146,298
+1% +$18.4M 0.18% 118
2014
Q3
$1.3B Buy
10,847,973
+1,009,530
+10% +$121M 0.18% 121
2014
Q2
$1.06B Buy
9,838,443
+1,324,873
+16% +$143M 0.14% 149
2014
Q1
$848M Sell
8,513,570
-1,694,608
-17% -$169M 0.12% 181
2013
Q4
$943M Sell
10,208,178
-288,149
-3% -$26.6M 0.13% 168
2013
Q3
$878M Sell
10,496,327
-3,179,213
-23% -$266M 0.13% 168
2013
Q2
$1.12B Buy
+13,675,540
New +$1.12B 0.18% 114